Freedland SJ - Search Results

1

Racial Discrepancies in Overall Survival among Men Treated with ²²³Radium.

Zhao H, Howard LE, De Hoedt A, Terris MK, Amling CL, Kane CJ, Cooperberg MR, Aronson WJ, Klaassen Z, Polascik TJ, Vidal AC, Freedland SJ. Zhao H, et al. Among authors: freedland sj. J Urol. 2020 Feb;203(2):331-337. doi: 10.1097/JU.0000000000000524. Epub 2019 Sep 3. J Urol. 2020. PMID: 31479407

2

Can we lower the mortality rate of black men with prostate cancer?

Aronson WJ, Freedland SJ. Aronson WJ, et al. Among authors: freedland sj. J Urol. 2000 Jan;163(1):150-1. J Urol. 2000. PMID: 10604334 No abstract available.

3

Clinical characteristics in black and white men with prostate cancer in an equal access medical center.

Freedland SJ, Sutter ME, Naitoh J, Dorey F, Csathy GS, Aronson WJ. Freedland SJ, et al. Urology. 2000 Mar;55(3):387-90. doi: 10.1016/s0090-4295(99)00461-6. Urology. 2000. PMID: 10699616

4

Race is not an independent predictor of biochemical recurrence after radical prostatectomy in an equal access medical center.

Freedland SJ, Jalkut M, Dorey F, Sutter ME, Aronson WJ. Freedland SJ, et al. Urology. 2000 Jul;56(1):87-91. doi: 10.1016/s0090-4295(00)00587-2. Urology. 2000. PMID: 10869631

5

Multivariate analysis of race and adverse pathologic findings after radical prostatectomy.

Freedland SJ, Dorey F, Aronson WJ. Freedland SJ, et al. Urology. 2000 Nov 1;56(5):807-11. doi: 10.1016/s0090-4295(00)00754-8. Urology. 2000. PMID: 11068307

6

Preoperative PSA velocity and doubling time do not predict adverse pathologic features or biochemical recurrence after radical prostatectomy.

Freedland SJ, Dorey F, Aronson WJ. Freedland SJ, et al. Urology. 2001 Mar;57(3):476-80. doi: 10.1016/s0090-4295(00)01016-5. Urology. 2001. PMID: 11248623

7

Collecting duct renal cell carcinoma: clinical study of a rare tumor.

Chao D, Zisman A, Pantuck AJ, Gitlitz BJ, Freedland SJ, Said JW, Figlin RA, Belldegrun AS. Chao D, et al. Among authors: freedland sj. J Urol. 2002 Jan;167(1):71-4. doi: 10.1016/s0022-5347(05)65385-2. J Urol. 2002. PMID: 11743278

8

Percent prostate needle biopsy tissue with cancer is more predictive of biochemical failure or adverse pathology after radical prostatectomy than prostate specific antigen or Gleason score.

Freedland SJ, Csathy GS, Dorey F, Aronson WJ. Freedland SJ, et al. J Urol. 2002 Feb;167(2 Pt 1):516-20. doi: 10.1016/S0022-5347(01)69076-1. J Urol. 2002. PMID: 11792909

9

Effect of ketorolac on renal function after donor nephrectomy.

Freedland SJ, Blanco-Yarosh M, Sun JC, Hale SJ, Elashoff DA, Rajfer J, Gritsch HA. Freedland SJ, et al. Urology. 2002 Jun;59(6):826-30. doi: 10.1016/s0090-4295(02)01514-5. Urology. 2002. PMID: 12031361

10

Improved risk stratification for biochemical recurrence after radical prostatectomy using a novel risk group system based on prostate specific antigen density and biopsy Gleason score.

Freedland SJ, Wieder JA, Jack GS, Dorey F, deKernion JB, Aronson WJ. Freedland SJ, et al. J Urol. 2002 Jul;168(1):110-5. J Urol. 2002. PMID: 12050502

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

780 results

Search Page

Filters